Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Sheng

Showing results (81-90 of 85) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 85 results.
Zhonghua Yi Xue Za Zhi|September 18, 2018
[Impact of first-line chemotherapy on renal function in patients with advanced upper tract urothelial carcinoma]X Li, X N Sheng, Z H Chi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 16, 2022
Toripalimab (anti-PD-1) versus high-dose interferon-α2b as adjuvant therapy in resected mucosal melanoma: a phase II randomized trialB Lian, L Si, Z H Chi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 2017
The natural history and patterns of metastases from mucosal melanoma: an analysis of 706 prospectively-followed patientsB Lian, C L Cui, L Zhou, et al.
The Journal of Experimental Medicine|November 7, 2001
Functional cloning of Src-like adapter protein-2 (SLAP-2), a novel inhibitor of antigen receptor signalingS J Holland, X C Liao, M K Mendenhall, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 23, 2023
Toripalimab plus axitinib versus sunitinib as first-line treatment for advanced renal cell carcinoma: RENOTORCH, a randomized, open-label, phase III studyX Q Yan, M J Ye, Q Zou, et al.
Pageof 9

Showing results (81-90 of 85) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 85 results.
Zhonghua Yi Xue Za Zhi|September 18, 2018
[Impact of first-line chemotherapy on renal function in patients with advanced upper tract urothelial carcinoma]X Li, X N Sheng, Z H Chi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 16, 2022
Toripalimab (anti-PD-1) versus high-dose interferon-α2b as adjuvant therapy in resected mucosal melanoma: a phase II randomized trialB Lian, L Si, Z H Chi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 2017
The natural history and patterns of metastases from mucosal melanoma: an analysis of 706 prospectively-followed patientsB Lian, C L Cui, L Zhou, et al.
The Journal of Experimental Medicine|November 7, 2001
Functional cloning of Src-like adapter protein-2 (SLAP-2), a novel inhibitor of antigen receptor signalingS J Holland, X C Liao, M K Mendenhall, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 23, 2023
Toripalimab plus axitinib versus sunitinib as first-line treatment for advanced renal cell carcinoma: RENOTORCH, a randomized, open-label, phase III studyX Q Yan, M J Ye, Q Zou, et al.
Pageof 9